http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
정호영,이지윤,박양춘,정인철,조충식,Jeong, Ho-young,Lee, Ji-yoon,Park, Yang-chun,Jung, In-chul,Cho, Chung-sik 대한한방내과학회 2017 大韓韓方內科學會誌 Vol.38 No.3
Objective: The purpose of this study was to develop a standard tool of pattern identification, which will be applied to clinical research, for benign prostatic hyperplasia. Method: The items and structure of the instrument were based on a review of the published literature in China and Korea. The advisory committee on this study included 11 kidney-endocrine professors of the Korean Medical Colleges Division and 4 Korean medicine doctors who had a doctor's degree in the Kidney-Endocrine Division. The advisory committee was questioned regarding pattern identification importance, symptom weight, treatment importance, changes in the symptoms, rare changes in the symptoms, and frequency of prescriptions regarding benign prostatic hyperplasia. Results: The Korean instrument of pattern identification was completed; it was composed of four questions for benign prostatic hyperplasia. Conclusion: We sincerely look forward to improving the instrument through the continuous clinical studies.
원발성 간세포암의 발생원인에 대한 임상적 연구 - 2 . 간경변증 및 간세포암 환자들에서의 혈청 Selenium 치에 대한 비교 관찰 -
구자영(Ja Young Koo),박병채(Byung Chae Park),한병훈(Byung Hoon Han),이상욱(Sang Ook Lee),서승연(Sung Yun Suh),정인철(In Chul Chung),조무연(Moo Yun Cho) 대한소화기학회 1989 대한소화기학회지 Vol.21 No.4
N/A Whether or not serum selenium concentrations were changed was evaluated in patients with liver cirrhosis and hepatocellular carcinoma. Serum selenium levels among the patients with liver cirrhosis (10.08±1.99 ug/dl) and hepatocellular carcinoma (9.76±1.51 ug/dl) were significantly lower (p<0.05, p<0.005) as compared to the controls (11.49±1.77 pg/dl). These data suggest that a low serum selenium concnetrations observed in patients with liver cirrhosis may be one of risk factors in the development of hepatocellular carcinoma.
김종우 ( Jong Woo Kim ),정선용 ( Sun Yong Chung ),서현욱 ( Hyun Uk Suh ),정인철 ( In Chul Jung ),이승기 ( Seung Gi Lee ),김보경 ( Bo Kyoung Kim ),김근우 ( Geun Woo Kim ),이재혁 ( Jae Hyuk Lee ),김낙형 ( Lak Hyung Kim ),김태헌 ( Ta 대한한방신경정신과학회 2010 동의신경정신과학회지 Vol.21 No.2
Objectives: The aim of this study was to investigate the characteristics of Hwa-Byung(HB) patients, draw the clinical key issue of HB, and provide the data as the basis for development of Clinical Guideline of HB. Methods: The study participants included 151 subjects who thought they have HB in 9 site. For all patients, we used HB epidemiologic study protocol, which include the Korean version of the Structured Clinical Interview for the DSM-IV Diagnosis (SCID-1), diagnostic criteria of HB, symptoms check list, pattern identification tool, psychiastric psychological questionnaires, and Framingham coronary risk score(FRS). Results: 1. For all participants, 62 % of subjects were diagnosed with HB. These patients had comorbid DSM-IV diagnoses with depression (65%) and anxiety (27%), But 22% of these patients had only HB. 2. HB patients had various physical symptoms when visiting, were diagnosed as various disease, and undergone medical treatments in the past. Among the diagonsed illness, Gastronitestinal diseases (51.6%), psychiatric disorders(40.9%), endocrine diseases(39.8%) were being the most frequent. The frequent physical symptoms of HB patients reported were chest discomfort, head ache, palpitation, frequent sigh, amnesia, shoulder pain, dry mouth, eye fatigue etc. 3. HB patients had high scores in psychologic questionares, CES-D, STAI, and STAXI. It means that HB patients might be low-level emotional stability. 4. Participant had negative opinion about the treatment of HB that it would be difficult or impossible (65.7%), but they neglect the need of medical treatment. Conclusions: This result shows that HB is comorbid with various psychiatric disease, but it has different physio-psychological symptoms from others and there were only HB patients. So we identify HB is independent disease. Moreover, there were the wrong perception of HB which blocking treatments. These problems support that the necessity of development of Clinical Guideline of HB.